Enzymatic inactivation of 6-keto-prostaglandin E1 in vitro: Comparison with prostaglandin E1
- 1 April 1984
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 33 (8) , 1277-1284
- https://doi.org/10.1016/0006-2952(84)90181-3
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Formation of 6‐keto prostaglandin E1 in mammalian kidneysBritish Journal of Pharmacology, 1983
- 6-Keto-Prostaglandin E1: Its Formation by Platelets from Prostacyclin and Resistance to Pulmonary DegradationPharmacology, 1983
- Prostacyclin is not a circulating hormone in manProstaglandins, 1982
- Comparison of the pulmonary, hepatic and renal extraction of PGI2 and 6-KETO-PGE1European Journal of Pharmacology, 1982
- 6-Keto-prostaglandin E1 is not equipotent to prostacyclin (PGI2) as an antiaggregatory agentProstaglandins, 1980
- Human plasma transforms prostacyclin (PGI2) into a platelet antiaggregatory substance which contracts isolated bovine coronary arteriesProstaglandins, 1980
- Hepatic metabolism of prostacyclin (PGI2) in the rabbit: Formation of a potent novel inhibitor of platelet aggregationBiochemical and Biophysical Research Communications, 1980
- Inhibition of vasoconstrictor responses by 6-keto-PGE1 in the feline mesenteric vascular bedProstaglandins, 1980
- 6-keto-prostaglandin E1 inhibits the aggregation of human plateletsEuropean Journal of Pharmacology, 1979
- Hypotensive and renovascular actions of 6-keto-prostaglandin E1, a metabolite of prostacyclinEuropean Journal of Pharmacology, 1979